| __timestamp | ADMA Biologics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 91733000 |
| Thursday, January 1, 2015 | 6745968 | 87644000 |
| Friday, January 1, 2016 | 8494742 | 92365000 |
| Sunday, January 1, 2017 | 18092835 | 85656000 |
| Monday, January 1, 2018 | 22502922 | 88196000 |
| Tuesday, January 1, 2019 | 25910757 | 89971000 |
| Wednesday, January 1, 2020 | 35050817 | 93413000 |
| Friday, January 1, 2021 | 42896889 | 91355000 |
| Saturday, January 1, 2022 | 52458024 | 113676000 |
| Sunday, January 1, 2023 | 59020000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, ADMA Biologics, Inc. and Taro Pharmaceutical Industries Ltd. have showcased contrasting trends in their SG&A efficiency. From 2014 to 2023, ADMA Biologics saw a staggering 1,125% increase in SG&A expenses, reflecting its aggressive growth strategy. In contrast, Taro Pharmaceutical's expenses grew by a modest 116%, indicating a more stable approach.
By 2023, Taro's SG&A expenses were nearly three times higher than ADMA's, highlighting its larger operational scale. However, the data for 2024 is incomplete, leaving room for speculation on future trends. This analysis underscores the importance of strategic financial management in the pharmaceutical industry, where balancing growth and efficiency can define a company's success.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Opthea Limited and ADMA Biologics, Inc.
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights